Unlike GALNT2 and TRMT2A, whose evidence of involvement in AD are limited, MFGE8 (a.k.a. medin) is strongly linked to AD, as it interacts directly with amyloid-β to promote its aggregation and it is associated with cognitive decline (43). Here, TRMT2A is linked to Alzheimer disease.